was approved in Europe in September as a subcutaneous injection offering a patient-friendly quarterly dosing schedule, as opposed to fortnightly and sometimes monthly dosing for Cimzia injections.

In April 2008, certolizumab pegol (Cimzia; UCB), a tumour-necrosis factor ... certolizumab pegol is distinguished by its monthly, home-injection maintenance dosing. Options for reducing ...

The recommended dose of Cimzia for adults with moderate-to-severe plaque psoriasis is 400 mg (given as two subcutaneous injections of 200 mg each) every other week. For some patients (with body ...